Microhealth
Rare Disease-Focused Care Delivery and Evidence Generation Platform
* Category leading RWE platform generating differentiated data through combination of a provider community and patient-reported outcomes; delivering personalized and comparative evidence at the point of care * Singular network architecture and data capturing capabilities help identify patients with unmet needs in real-time; unlocking opportunities to improve health outcomes and additional revenue for pharma * Microhealth has achieved product-market fit in the hemophilia and rare blood disorders space Today, we are the world's leader in digital hematology: - Our US hemophilia network covers 33%+ of patients on prophylaxis and 50%+ of hemophilia treatment centers - Average active-user retention is 52 months - Trusted by leading pharmaceutical sponsors: Novo Nordisk, Sanofi, Roche and Pfizer
- Website
- microhealth.com
- City
- Claymont
- Country
- United States
- YC batch
- Summer 2015
- Team
- 25 people
- Stage
- Early stage
- AI-native
- Yes
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Claymont
Claim this profile
Free and instant: prove you run microhealth.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Microhealth across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Microhealth's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
